PE Hub26d
PE-backed Cosette Pharmaceuticals to acquire Mayne Pharma for $430m
Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million ...
NJBIZ27d
Cosette Pharma acquires Mayne Pharma in $430M deal
Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...
capitalbrief29d
Mayne Pharma shares soar on sale to Cosette Pharmaceuticals
The news: ASX small cap Mayne Pharma saw its shares surge more than 30% after US-based Cosette Pharmaceuticals agreed to acquire the Adelaide-based specialty pharmaceutical company. The numbers: Mayne ...
ENDPOINTS NEWS29d
More biotechs an­nounce share buy­backs; Cosette to buy Mayne Phar­ma
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The Australian Financial Review29d
US pharma giant Cosette makes $672m bid for Mayne Pharma
Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...
FiercePharma29d
Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy
With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...
BioSpace1mon
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire ...
The Pharma Letter1mon
Cosette to acquire Australia’s Mayne Pharma
US drugmaker Cosette Pharmaceuticals has entered into a definitive agreement to acquire all the outstanding shares of Australia-based Mayne Pharma (ASX: MYX) with the aim of expanding its health ...
smallcaps1mon
Mayne Pharma board backs $672 million takeover bid from Cosette Pharma
Mayne Pharma (ASX: MYX) has received a takeover offer at a price of $7.40 per share from US-based pharmaceutical company Cosette Pharma, valuing the company at $672 million. Cosette has a portfolio of ...
GitHub1mon
da86a094e768f000-vs_replace.txt
r0.xyz = max(float3(6.10351999e-005,6.10351999e-005,6.10351999e-005), v3.xyz); r1.xyz = r0.xyz * float3(0.947867274,0.947867274,0.947867274) + float3(0.0521326996,0. ...
Yahoo Finance1mon
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
BRIDGEWATER, N.J., February 20, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it ...
Business Wire1mon
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...